SCHEMBL5158009

SCHEMBL5158009

COC(=O)c1cc2c(c3cc(C)ccc13)C=CC(c1ccccc1)(c1ccc([N+]3(C)CCCCC3)cc1)O2

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
HTT P42858 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
PSMD14 O00487 1/20 0.31
USP2 O75604 1/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 1/20 0.31
PTK2B Q14289 1/20 0.31
ESR2 Q92731 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAPT P10636 2/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5156144 0.84 ALDH1A1 (0.31) ALDH1A1HTTNPSR1PSMD14USP2
SCHEMBL5158450 0.84 ALDH1A1 (0.31) ALDH1A1HTTNPSR1PSMD14USP2
SCHEMBL4594654 0.84 MAPT (0.32) MAPT
SCHEMBL10026219 0.75 TSHR (0.36) ALDH1A1POLBHPGDHSD17B10MAPT
SCHEMBL4593620 0.73 MPL (0.33) MAPT
SCHEMBL5107478 0.70 NR4A2 (0.37) ALDH1A1HTTNPSR1POLBHPGD
SCHEMBL5422759 0.67 NPSR1 (0.35) ALDH1A1HTTNPSR1HPGDMAPT
SCHEMBL361912 0.66 LCK (0.45) ALDH1A1HTTHPGDMAPTKDM4E
SCHEMBL13061587 0.65 ALOX5 (0.43) ALDH1A1HTTHPGDMAPTKDM4E
SCHEMBL15693690 0.65 DHODH (0.35) ALDH1A1HTTNPSR1USP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1410784-B1 Cosmetic composition comprising an oil phase and a naphthopyran dye and method OREAL (FR) 2007-02-07 EP claimed
US-20050276767-A1 Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes L'OREAL (FR) 2005-12-15 US claimed
US-20050276767-A1 Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes L'OREAL (FR) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050276767-A1 Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes CUTA, TYR, TPSD1 ALDH1A1 652/4885HTT 4289/4885NPSR1 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.